Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.
- DOI
- 10.1016/j.jacl.2015.08.006
- Published
- 2015 Nov-Dec
- Container
- Journal of clinical lipidology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacl.2015.08.006,
title = {Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.},
author = {Moriarty PM and Thompson PD and Cannon CP and Guyton JR and Bergeron J and Zieve FJ and Bruckert E and Jacobson TA and Kopecky SL and Baccara-Dinet MT and Du Y and Pordy R and Gipe DA and ODYSSEY ALTERNATIVE Investigators},
year = {2015},
journal = {Journal of clinical lipidology},
doi = {10.1016/j.jacl.2015.08.006},
url = {https://doi.org/10.1016/j.jacl.2015.08.006}
}RIS
TY - JOUR TI - Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. AU - Moriarty PM AU - Thompson PD AU - Cannon CP AU - Guyton JR AU - Bergeron J AU - Zieve FJ AU - Bruckert E AU - Jacobson TA AU - Kopecky SL AU - Baccara-Dinet MT AU - Du Y AU - Pordy R AU - Gipe DA AU - ODYSSEY ALTERNATIVE Investigators PY - 2015 JO - Journal of clinical lipidology DO - 10.1016/j.jacl.2015.08.006 UR - https://doi.org/10.1016/j.jacl.2015.08.006 ER -
APA
PM, M., PD, T., CP, C., JR, G., J, B., FJ, Z., E, B., TA, J., SL, K., MT, B., Y, D., R, P., DA, G., & Investigators, O. A. (2015). Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.. Journal of clinical lipidology. https://doi.org/10.1016/j.jacl.2015.08.006